Literature DB >> 32042929

Closure of pulmonary cavity of a multidrug-resistant tuberculosis patient with catheter insertion - A case report.

Peize Zhang1, Weipeng Cao1, Taosheng Ye1, Guofang Deng1.   

Abstract

The treatment of multidrug-resistant tuberculosis (MDR-TB) relies heavily on optimal chemotherapy, but interventional therapies can be adopted as adjuvant treatment to speed up illness control and increase the cure rate. We present a case of a 31-year-old MDR-TB male patient with a massive pulmonary cavity in the right lower lung cured by chemotherapy with a catheter inserted in the cavity as adjuvant treatment. This case illustrated that early interventional therapy increases the treatment success rate for pulmonary MDR-TB patients with empyema and massive cavity without the need of major invasive surgery and consequently preserve lung functions.
© 2020 Published by Elsevier Ltd.

Entities:  

Keywords:  Adjuvant treatment; Cure; Interventional therapy; Massive cavity; Multidrug-resistant tuberculosis (MDR-TB)

Year:  2020        PMID: 32042929      PMCID: PMC6997894          DOI: 10.1016/j.jctube.2020.100146

Source DB:  PubMed          Journal:  J Clin Tuberc Other Mycobact Dis        ISSN: 2405-5794


  8 in total

Review 1.  Multidrug-resistant pulmonary tuberculosis: surgical challenges.

Authors:  Michael J Weyant; John D Mitchell
Journal:  Thorac Surg Clin       Date:  2012-06-12       Impact factor: 1.750

Review 2.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

3.  Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis.

Authors:  Ebru Unsal; Müjgan Güler; Ruhsar Ofluoglu; Nermin Capan; Filiz Cimen
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  Open drainage of massive tuberculous empyema with progressive reexpansion of the lung: an old concept revisited.

Authors:  S M Ali; A A Siddiqui; J S McLaughlin
Journal:  Ann Thorac Surg       Date:  1996-07       Impact factor: 4.330

Review 5.  Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  Hong-Bin Xu; Rui-Hua Jiang; Ling Li
Journal:  J Antimicrob Chemother       Date:  2011-06-03       Impact factor: 5.790

6.  Lobar Collapse Therapy Using Endobronchial Valves as a New Complementary Approach to Treat Cavities in Multidrug-Resistant Tuberculosis and Difficult-to-Treat Tuberculosis: A Case Series.

Authors:  Lorenzo Corbetta; Ariela Tofani; Flavio Montinaro; Lucio Michieletto; Loris Ceron; Chiara Moroni; Pier Giorgio Rogasi
Journal:  Respiration       Date:  2016-10-12       Impact factor: 3.580

7.  Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.

Authors:  N Ahmad; A Javaid; A Basit; A K Afridi; M A Khan; I Ahmad; S A S Sulaiman; A H Khan
Journal:  Int J Tuberc Lung Dis       Date:  2015-09       Impact factor: 2.373

Review 8.  Pulmonary resection for patients with multidrug-resistant tuberculosis based on survival outcomes: a systematic review and meta-analysis.

Authors:  Hyunsuk Frank Roh; Jihoon Kim; Seung Hyuk Nam; Jung Mogg Kim
Journal:  Eur J Cardiothorac Surg       Date:  2017-10-01       Impact factor: 4.534

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.